Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein

Journal of Lipid Research

Volumn 44, Issue 6, 2003, Pages 1124-1131

  Kawai, Yoshichika ^a   Kato, Yoji ^b   Fujii, Hiroyuki ^a   Makino, Yuko ^a   Mori, Yoko ^a   Naito, Michitaka ^c,d   Osawa, Toshihiko ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b UNIVERSITY OF HYOGO   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SUGIYAMA JOGAKUEN UNIVERSITY   (Japan)

Author keywords

13 hydroperoxyoctadecadienoic acid; Lipid peroxidation; Protein modification

Indexed keywords

13 HYDROPEROXYOCTADECADIENOIC ACID; DECANOIC ACID; LINOLEIC ACID; LYSINE; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; ATHEROSCLEROSIS; DECOMPOSITION; ESTERIFICATION; FOAM CELL; HYPERCHOLESTEROLEMIA; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; TISSUE SECTION;

AMIDES; ANIMALS; ANTIBODIES; AORTA; ARTERIOSCLEROSIS; CROSS REACTIONS; DICARBOXYLIC ACIDS; EPITOPES; FATTY ACIDS, UNSATURATED; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LINOLEIC ACIDS; LIPID PEROXIDATION; LIPID PEROXIDES; LYSINE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PROTEINS; RABBITS; TIME FACTORS;

EID: 0142042370     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200442-JLR200     Document Type: Article

References (29)

1. Steinberg, D. 1995. Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 369: 39-48.
2. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
3. Steinbrecher, U. P., J. L. Witztum, S. Parthasarathy, and D. Steinberg. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7: 135-143.
4. Steinbrecher, U. P. 1987. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262: 3603-3608.
5. ε-(2-propenal)lysine in proteins. Arch. Biochem. Biophys. 346: 45-52.
6. Uchida, K., S. Toyokuni, K. Nishikawa, S. Kawakishi, H. Oda, H. Hiai, and E. R. Stadtman. 1994. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry. 33: 12487-12494.
7. Uchida, K., K. Itakura, S. Kawakishi, H. Hiai, S. Toyokuni, and E. R. Stadtman. 1995. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 324: 241-248.
8. Uchida, K., M. Kanematsu, K. Sakai, T. Matsuda, N. Hattori, Y. Mizuno, D. Suzuki, T. Miyata, N. Noguchi, E. Niki, and T. Osawa. 1998. Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA. 95: 4882-4887.
9. Uchida, K., M. Kanematsu, Y. Morimitsu, T. Osawa, N. Noguchi, and E. Niki. 1998. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273: 16058-16066.
10. 2+/ascorbate/EDTA-induced lipid peroxidation. Biochim. Biohys. Acta. 1166: 264-274.
11. Kamido, H., A. Kuksis, L. Marai, and J. J. Myher. 1993. Identification of core aldehydes among in vitro peroxidation products of cholesteryl esters. Lipids. 28: 331-336.
12. Hoppe, G., A. Ravandi, D. Herrera, A. Kuksis, and H. F. Hoff. 1997. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J. Lipid Res. 38: 1347-1360.
13. Salomon, R. G., G. Subbanagounder, U. Singh, J. O'Neil, and H. F. Hoff. 1997. Oxidation of low-density lipoproteins produces levuglandin-protein adducts. Chem. Res. Toxicol. 10: 750-759.
14. Kaur, K., R. G. Salomon, J. O'Neil, and H. F. Hoff. 1997. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem. Res. Toxicol. 10: 1387-1396.
15. Kim, J. G., F. Sabbagh, N. Santanam, J. N. Wilcox, R. M. Medford, and S. Parthasarathy. 1997. Generation of a polyclonal antibody against lipid peroxide-modified proteins. Free Radic. Biol. Med. 23: 251-259.
16. Kato, Y., Y. Makino, and T. Osawa. 1997. Characterization of a specific polyclonal antibody against 13-hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL. J. Lipid Res. 38: 1334-1346.
17. Kato, Y., and T. Osawa. 1998. Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: contribution of esterified fatty acid-protein adduct to oxidative modification of LDL. Arch. Biochem. Biophys. 351: 106-114.
18. ε-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J. Biol. Chem. 274: 20406-20414.
19. Kato, Y., K. Tokunaga, and T. Osawa. 1996. Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL. Biochem. Biophys. Res. Commun. 226: 923-927.
20. Kang, M. H., Y. Kawai, M. Naito, and T. Osawa. 1999. Dietary defatted sesame flour decreases susceptibility to oxidative stress in hypercholesterolemic rabbits. J. Nutr. 129: 1885-1890.
21. ε -(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271: 9982-9986.
22. Gillotte, K. L., S. Hörkkö, J. L. Witztum, and D. Steinberg. 2000. Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors. J. Lipid Res. 41: 824-833.
23. Fruebis, J., S. Parthasarathy, and D. Steinberg. 1992. Evidence for a concerted reaction between lipid hydroperoxides and polypeptides. Proc. Natl. Acad. Sci. USA. 89: 10588-10592.
24. Kim, J. G., W. R. Taylor, and S. Parthasarathy. 1999. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody. Atherosclerosis. 143: 335-340.
25. Bird, D. A., K. L. Gillotte, S. Hörkkö, P. Friedman, E. A. Dennis, J. L. Witztum, and D. Steinberg. 1999. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc. Natl. Acad. Sci. USA. 96: 6347-6352.
26. Hörkkö, S., D. A. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J. A. Berliner, P. Friedman, E. A. Dennis, L. K. Curtiss, W. Palinski, and J. L. Witztum. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103: 117-128.
27. Salomon, R. G., W. Sha, C. Brame, K. Kaur, G. Subbanagounder, J. O'Neil, H. F. Hoff, and L. J. Roberts II. 1999. Protein adducts of iso [4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein. J. Biol. Chem. 274: 20271-20280.
28. Esterbauer, H., and P. Ramos. 1996. Chemistry and pathophysiology of oxidation of LDL. Rev. Physiol. Biochem. Pharmacol. 127: 31-64.
29. Onorato, J. M., A. J. Jenkins, S. R. Thorpe, and J. W. Baynes. 2000. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine. J. Biol. Chem. 275: 21177-21184.